By Kate Abnett and Christian Levaux BRUSSELS (Reuters) – Global efforts to address climate change will be dealt a severe blow if U.S.
By Scott Murdoch SYDNEY (Reuters) – Asian dollar bond issuance is expected to rise around 20% in 2025 over last year, driven by
LONDON (Reuters) – From China to Europe, Canada to Mexico, world markets are already reeling from Donald Trump’s promise to jack up
Investing.com– ASEAN economies are entering 2025 with a strong starting position for growth, BofA analysts said in a note, citing resilient domestic
A look at the day ahead in European and global markets from Ankur Banerjee The dollar stood tall on Wednesday boosted by elevated
By Shivangi Acharya and Nikunj Ohri NEW DELHI (Reuters) – After world-beating economic growth last year, India’s policymakers are scrambling to head off
By Ankur Banerjee SINGAPORE (Reuters) – Asian stocks drifted lower on Wednesday, with a robust dollar keeping the yen pinned near six-month lows
KUALA LUMPUR (Reuters) – Malaysia will offer a slew of tax incentives for companies and workers in its special economic zone with
BEIJING (Reuters) – China will expand the scope of home appliance trade-ins this year to 12 categories from the eight included last
By Leika Kihara TOKYO (Reuters) – The Bank of Japan will likely keep raising interest rates in the coming years as inflation appears
By Hyunjoo Jin and Joyce Lee SEOUL (Reuters) -Samsung Electronics released on Wednesday a fourth-quarter operating profit estimate that missed analyst estimates by
SYDNEY (Reuters) – Australian consumer price inflation crept up from three-year lows in November as electricity costs jumped, but a drop in
By Nick Carey LONDON (Reuters) – British luxury automaker Rolls-Royce (OTC:RYCEY) said on Wednesday it will invest 300 million pounds ($376 million) to
SEOUL (Reuters) – South Korea’s acting President Choi Sang-mok on Wednesday said the government will work with the central bank and regulators
By Tom Westbrook SINGAPORE (Reuters) – The dollar stood tall on Wednesday and the yen sagged close to levels that drew intervention last
(Reuters) – Biotech firm Maze Therapeutics, backed by Third Rock Ventures, revealed a profit for the first nine months of 2024 in
